A detailed history of Madison Park Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Madison Park Capital Advisors, LLC holds 1,185 shares of ABBV stock, worth $230,127. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,185
Previous 1,180 0.42%
Holding current value
$230,127
Previous $215 Million 5.46%
% of portfolio
0.17%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $773 - $903
5 Added 0.42%
1,185 $203 Million
Q1 2024

Apr 05, 2024

BUY
$159.82 - $182.1 $188,587 - $214,878
1,180 New
1,180 $215 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Madison Park Capital Advisors, LLC Portfolio

Follow Madison Park Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Park Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Park Capital Advisors, LLC with notifications on news.